Table 1.
Clinical and biochemical characteristics of the study population.
| Variables | Levels | Non-Obese | Obese | p-Value |
|---|---|---|---|---|
| Demographic Data | ||||
| Age, years | Mean ± SD | 36.96 ± 14.7 | 41.49 ± 16.2 | 0.005 * |
| Sex | Female | 78 (33.9) | 65 (42.2) | 0.10 |
| Male | 152 (66.1) | 89 (57.8) | ||
| BMI, kg/m2 | Mean ± SD | 21.36 ± 3.2 | 33.65 ± 3.9 | <0.001 * |
| Comorbidities | ||||
| T2DM | Positive | 99 (43.0) | 78 (50.6) | 0.14 |
| Dyslipidemia | Positive | 26 (11.3) | 35 (22.7) | 0.004 * |
| Hypertension | Positive | 27 (11.7) | 31 (20.1) | 0.029 * |
| SBP, mmHg | 123.62 ± 18.0 | 126.14 ± 18.6 | 0.18 | |
| DBP, mmHg | 72.5 ± 9.95 | 72.11 ± 9.60 | 0.65 | |
| Laboratory Data | ||||
| Glycemic state | Serum glucose, mmol/L | 5.7 (4.7–6.9) | 6.0 (5.24–7.7) | 0.003 * |
| Glycosylated hemoglobin (HbA1c), % | 6.0 ± 1.67 | 6.27 ± 1.77 | 0.13 | |
| Serum insulin, mIU/L | 160 (73.1–324.5) | 220 (86–448) | 0.006 * | |
| Lipid profile | Triglyceride, mmol/L | 1.51 (1.03–2.3) | 1.58 (1.04–2.5) | 0.80 |
| Total cholesterol, mmol/L | 4.83 ± 0.99 | 4.85 ± 1.07 | 0.85 | |
| HDL-cholesterol, mmol/L | 1.16 (0.97–1.35) | 1.14 (0.97–1.33) | 0.61 | |
| LDL-cholesterol, mmol/L | 2.73 (2.24–3.53) | 2.91 (2.19–3.5) | 0.74 |
Data are shown as number (percentage), mean ± standard deviation (SD), or median (interquartile range). Two-sided Chi-square, Fisher’s exact, Student’s t, and Mann–Whitney U tests were used. (*) Indicates significance at p-value < 0.05. Abbreviations; T2DM: type 2 diabetes mellitus, SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein.